AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CHEMED CORP

Regulatory Filings May 19, 2021

Preview not available for this file type.

Download Source File

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8 - K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported):

May 19, 2021

CHEMED CORPORATION

(Exact name of registrant as specified in its charter)

Delaware 1 - 8351 31 - 0791746
(State or other ‎ jurisdiction of ‎ incorporation) (Commission File Number) (I.R.S. Employer ‎ Identification ‎ Number)

2600 First Financial Center , 255 East 5th Street , Cincinnati , OH 45202

(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code:

( 513 ) 762 - 6690

Title of each class Trading symbol Name of each exchange on which registered
Capital stock $1 par value CHE NYSE

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

[_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12)

[_] Pre-commencement communications pursuant to Rule 14d-2(b) under Exchange Act (17 CFR 240-14d-2(b))

[_] Pre-commencement communications pursuant to Rule 13e-4 (c) under Exchange Act (17 CFR 240-13e-4(c))

Securities registered pursuant to 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company [_]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [_]

Page 1 of 4

Item 5.07 Submission of Matters to a Vote of Security Holders

(a) On May 17, 2021, Chemed Corporation held its annual meeting of stockholders.

(b) Stockholders voted on the matters set forth below:

Item 1. Election of Directors. The following directors, who constitute the entire Board of Directors, were elected at the meeting by the votes indicated:

Nominee For Against Abstentions Broker non-votes
Kevin J. McNamara 13,880,604 181,275 12,649 770,879
Ron DeLyons 14,005,609 54,011 14,908 770,879
Joel F. Gemunder 12,674,528 1,286,543 113,459 770,879
Patrick P. Grace 11,356,020 2,245,703 472,806 770,879
Christopher J. Heaney 13,975,499 85,982 13,048 770,879
Thomas C. Hutton 13,766,403 295,963 12,163 770,879
Andrea R. Lindell 13,632,787 328,681 113,062 770,879
Thomas P. Rice 13,735,348 226,893 112,289 770,879
Donald E. Saunders 13,331,746 629,644 113,139 770,879
George J. Walsh III 12,860,870 1,101,516 112,143 770,879

Item 2. Ratification of Independent Accountants. The proposal to ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the company’s independent accountants for the year ending December 31, 2021, was approved with the following votes:

Voted
For 14,332,684
Against 499,324
Abstain 13,400
Broker non-votes -

Item 3. Executive Compensation. The proposal to approve, on a non-binding basis, the Company’s executive compensation program, was approved with the following votes:

Voted
For 13,373,906
Against 673,428
Abstain 27,195
Broker non-votes 770,879

Page 2 of 4

Item 4. Stockholder Proposal. The stockholder proposal requesting a semi-annual report on (a) the Company’s policies on political spending and (b) political contributions made was approved with the following votes:

Voted
For 11,159,406
Against 2,764,206
Abstain 150,917
Broker non-votes 770,879

Page 3 of 4

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

/s/ Michael D. Witzeman
Michael D. Witzeman
Vice President and Controller

Page 4 of 4

Talk to a Data Expert

Have a question? We'll get back to you promptly.